Vanguard Group
SYRS

Vanguard Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-268,154
Closed -$61.7K 4312
2024
Q4
$61.7K Sell
268,154
-685,159
-72% -$158K ﹤0.01% 4197
2024
Q3
$2.05M Sell
953,313
-14,904
-2% -$32K ﹤0.01% 3551
2024
Q2
$5M Buy
968,217
+40,171
+4% +$207K ﹤0.01% 3264
2024
Q1
$4.97M Buy
928,046
+163,234
+21% +$873K ﹤0.01% 3304
2023
Q4
$5.96M Buy
764,812
+236,620
+45% +$1.84M ﹤0.01% 3210
2023
Q3
$2.09M Buy
528,192
+30,984
+6% +$122K ﹤0.01% 3566
2023
Q2
$1.57M Buy
497,208
+9,986
+2% +$31.5K ﹤0.01% 3745
2023
Q1
$1.3M Buy
487,222
+14,492
+3% +$38.7K ﹤0.01% 3834
2022
Q4
$1.7M Sell
472,730
-14,803
-3% -$53.1K ﹤0.01% 3721
2022
Q3
$3.14M Sell
487,533
-2,395,075
-83% -$15.4M ﹤0.01% 3563
2022
Q2
$2.78M Buy
2,882,608
+627,078
+28% +$604K ﹤0.01% 3664
2022
Q1
$2.69M Sell
2,255,530
-534,843
-19% -$637K ﹤0.01% 3829
2021
Q4
$9.1M Sell
2,790,373
-195,605
-7% -$638K ﹤0.01% 3276
2021
Q3
$13.3M Buy
2,985,978
+210,402
+8% +$941K ﹤0.01% 3082
2021
Q2
$15.1M Buy
2,775,576
+43,152
+2% +$235K ﹤0.01% 2991
2021
Q1
$20.4M Buy
2,732,424
+687,720
+34% +$5.14M ﹤0.01% 2775
2020
Q4
$22.2M Buy
2,044,704
+11,281
+0.6% +$122K ﹤0.01% 2587
2020
Q3
$18M Buy
2,033,423
+132,050
+7% +$1.17M ﹤0.01% 2515
2020
Q2
$20.3M Buy
1,901,373
+103,005
+6% +$1.1M ﹤0.01% 2420
2020
Q1
$10.7M Buy
1,798,368
+1,266
+0.1% +$7.51K ﹤0.01% 2587
2019
Q4
$12.4M Buy
1,797,102
+1,408
+0.1% +$9.73K ﹤0.01% 2753
2019
Q3
$18.6M Buy
1,795,694
+30,684
+2% +$318K ﹤0.01% 2522
2019
Q2
$16.3M Buy
1,765,010
+863,074
+96% +$7.99M ﹤0.01% 2615
2019
Q1
$8.24M Buy
901,936
+221,796
+33% +$2.03M ﹤0.01% 2925
2018
Q4
$3.79M Sell
680,140
-364,799
-35% -$2.03M ﹤0.01% 3179
2018
Q3
$12.4M Buy
1,044,939
+43,562
+4% +$519K ﹤0.01% 2808
2018
Q2
$10.2M Buy
1,001,377
+82,116
+9% +$838K ﹤0.01% 2894
2018
Q1
$11.9M Buy
919,261
+336,762
+58% +$4.37M ﹤0.01% 2739
2017
Q4
$5.67M Buy
582,499
+32,515
+6% +$316K ﹤0.01% 3083
2017
Q3
$8.1M Buy
549,984
+167,381
+44% +$2.46M ﹤0.01% 2910
2017
Q2
$6.16M Buy
382,603
+250,507
+190% +$4.03M ﹤0.01% 3010
2017
Q1
$2.1M Buy
132,096
+96,729
+274% +$1.54M ﹤0.01% 3367
2016
Q4
$430K Buy
35,367
+19,940
+129% +$242K ﹤0.01% 3761
2016
Q3
$214K Buy
+15,427
New +$214K ﹤0.01% 3891